Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04376333 · ClinicalTrials.gov registry record · NA
Individualized Assessment and Treatment for TMD
A NA study, sponsored by UConn Health.
- Active
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT04376333 is a NA study that is active but no longer recruiting, run by UConn Health. The registered enrollment target is 160 participants.
The verdict
NCT04376333, a NA study, is active but no longer recruiting, sponsored by UConn Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
Temporomandibular/orofacial pain disorders (TMD) are a group of painful conditions with multiple determinants.This proposal has two main goals: 1) to test a highly individualized, adaptive treatment for TMD that has potential to be more effective than other psychosocial treatments; and 2) to discover the mechanisms by which psychosocial treatments work in chronic pain. TMD patients (N=160) will be randomized to receive standard care (STD) + an individualized assessment and treatment program (IATP) or to standard care + conventional cognitive-behavioral treatment (STD+CBT). It is expected that the STD+IATP treatment will yield lower pain, depression and interference scores over time than STD+CBT, and that changes in coping ability will mediate the treatment effects on outcomes.
Interventions
- BEHAVIORAL Cognitive-Behavioral Treatment
- BEHAVIORAL Individualized Assessment and Treatment Program
- OTHER Standard Conservative Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2021-02-03 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04376333
The ClinicalTrials.gov registry entry for NCT04376333 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cognitive-Behavioral Treatment is the first listed.
NCT04376333 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04376333 about?
NCT04376333 is a clinical study titled "Individualized Assessment and Treatment for TMD". Temporomandibular/orofacial pain disorders (TMD) are a group of painful conditions with multiple determinants.This proposal has two main goals: 1) to test a highly individualized, adaptive treatment for TMD that has potential to be more effective than other psychosocial treatments; and 2) to discove...
What is the current status of trial NCT04376333?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2021-02-03. Estimated completion is 2027-06-30.
What interventions are being tested in trial NCT04376333?
The interventions under investigation include: Cognitive-Behavioral Treatment (BEHAVIORAL), Individualized Assessment and Treatment Program (BEHAVIORAL), Standard Conservative Care (OTHER).
Who is sponsoring clinical trial NCT04376333?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.